Tully & Holland Newsletter
Join our mailing list to be notified of the latest transactions. Join now >>Transactions
A selection of recently completed transactions by Tully & Holland, Inc.see listings>>
Mergers
Tully & Holland works on behalf of the seller to evaluate, recommend, structure and close the transaction. more info >>Aquisitions
On behalf of the buyer, Tully & Holland conducts searches, negotiates and structures the transaction and follows through to closing. more info >>Private Placements
Tully & Holland is licensed to assist clients in raising equity and debt for expansion, acquisitions or recapitalizations.more info >>
Valuations
Tully & Holland provides valuation services to current and prospective clients. more info >>
Tully & Holland
60 William Street, Suite 100
Wellesley, MA 02481
781.239.2900
info@tullyandholland.com
60 William Street, Suite 100
Wellesley, MA 02481
781.239.2900
info@tullyandholland.com
| Member SIPC | Member FINRA |
Press Releases
Tully & Holland, Inc. represents American Nutriceuticals, Inc.
November 12, 2002
Wellesley Hills, MA-based Tully & Holland, Inc. acted as financial advisor to American Nutriceuticals, Inc. in the sale of its assets to Internutra, LLC, a New York-based company. American Nutriceuticals is a leading early stage nutritional food company, which sought a partner or an equity infusion in order to fund its continued growth within this strategic steadily growing $600 million healthcare foodservice market.
ANI has developed a unique line of patented pureed foods that serves the needs of over 600,000 institutionalized individuals that may require, at any given time, to consume puree foods. The partnership with Internutra, Inc. will enable ANI to fund current growth and develop future proprietary product within this rapidly developing field.
ANI has developed a unique line of patented pureed foods that serves the needs of over 600,000 institutionalized individuals that may require, at any given time, to consume puree foods. The partnership with Internutra, Inc. will enable ANI to fund current growth and develop future proprietary product within this rapidly developing field.

